Fruquintinib as a Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer
Clinical trial NCT04296019 · UNKNOWN
Trial details
- NCT number
- NCT04296019
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2023-07-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.